loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Drug Master Files (DMF) for 29594 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Chemport Inc

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Chemport Inc (1)

    filter

    01 DHA930EE (1)

    filter

    01 United Kingdom (1)

    filter

    01 Active (1)

    filter

    01 Blank (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    CHEMPORT INC

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag United Kingdom
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      DHA930EE

      PDF Supplier PDF
      URL Supplier Web Content
      29594
      Active
      2015-07-27
      N/A
      II
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for Drug Master Files (DMF) for 29594 of Chemport Inc

      Looking for Drug Master Files (DMF) for 29594 of Chemport Inc 1

      20

      Chemport Inc, based in United Kingdom, is a pharmaceutical company.

      One of their notable products is DHA930EE, with a corresponding US DMF Number 29594.

      Remarkably, this DMF maintains an Active status since its submission on July 27, 2015, highlighting commitment to regulatory compliance.

      Post Enquiry
      POST ENQUIRY